ConTIPI Medical Ltd. received US Food and Drug Administration (FDA) approval to market its new product Provate, the first product of its kind to treat pelvic prolapse in women (such as the uterus and bladder). What makes Provate unique is that until...
healthy.io made two important announcements yesterday, first that they had received FDA approval for their smartphone based production to make take and ACR test to help diagnose chronic kidney disease which affects over 35 million Americans. T
Second the...
Medial EarlySign (earlysign.com), a leader in machine-learning based solutions to aid in early detection and prevention of high-burden diseases, announced its first suite of diabetes risk predictors for healthcare organizations. Expanding the company's portfolio of clinical risk predictors, these new diabetes-focused AlgoMarkers...
Magenta Medical, developer of heart failure solutions, based on proprietary miniaturized blood pump technology, announced a financing round led by global venture capital firm New Enterprise Associates (NEA), with participation from existing investors, including Pitango Venture Capital, JVC Investment Partners and a group of private investors led...
SofWave Medical Ltd., has developed a unique device to help individuals look their best without complicated surgery. SofWave has developed a Non-Invasive Fractional Ultrasound Technology for skin tightening. Today Sofwave announced they closed a $8.4M financing round, led by XT Hi-Tech and...
Biobeat’s smartwatch and patch connect to the cloud through either a smartphone or a dedicated gateway. The user will use one or the other device; whereas the watch is worn on the wrist the patch is to be placed anywhere on the...
Tyto Care, creator of the health care industry's first all-in-one modular device and Telehealth platform for on-demand, remote medical exams, today announced the nationwide availability of TytoHome, following a successful initial rollout in the Midwest. The TytoHome Telehealth solution, now available in...
Human Xtensions, which has developed robotic devices to serve as assistants in non-invasive surgery, is in the midst of its fourth funding round, at a value of $140 million. The lead investor in the latest round is Pesagot Investments, which is set...
